Trial intelligence / Profile preview

Prehospital hypertonic sodium versus normal saline in head trauma with decreased consciousness

IRCT20151003024317N10Phase 3Completed

Sponsor
Iran University of Medical Sciences
Start
Feb 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of hypertonic saline and sodium chloride in traumatic brain injury (TBI) (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Level of consciousness, Blood pressure and 2 more. Started Feb 2020; status: completed.

02

Drugs

hypertonic salinesodium chloride
03

Conditions

traumatic brain injury (TBI)

Beyond the preview

Go deeper on IRCT20151003024317N10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20151003024317N10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call